Skip to main content
Log in

Interferon treatment of uterine cervical precancerosis

  • Original Papers
  • Clinical Oncology or Epidemiology
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Summary

Human leukocyte interferon (HLI) was used in a randomized study of patients with precancerous states on the uterine cervix. The daily dose of HLI was 106 units and it was applied by the contraceptive pessary technique. In patients who had had only viral alterations on the cervix the treatment lasted 14 days (Singer et al. 1979) and in those with changed cytologic findings 21 days.

The cytologic findings of the interferon treated patients showed no progression of the pathologic process during the ensuing 2 years. In the control group, however, they showed the aggravation of the process and the patients were directed to surgical therapy.

The control of cytologic findings has been continued and is now performed at 3 month intervals.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Aurelian L, Praboth KG, Frost JK, Rosenshein N, Mantione J (1978) Immunologic markers for cervical histopathology. Acta Cytol 22:606

    Google Scholar 

  • Ikić D, Beck M, Turner V, Šooš E, Lulić V, Juzbašić M (1977a) Antiinvasive activity of human leukocyte interferon and human fibroblast interferon in vitro. Proc. Symp. on Preparation, Standardization and Clinical Use of Interferon. 11th Internat. Immunobiol. Symp. Yug. Acad. Sci. Arts, 8–9 June 1977, JAZU; Zagreb, pp 89–96

  • Ikić D, Smerdel S, Šooš E, Jušić D (1977b) Our experiences with topical use of interferon in viral diseases. Ibid, pp 123–133

  • Krušić J, Alač Z (1974) Prilog terapiji condylomata acuminata s humanim leukocitnim interferonom. Zbornik radova Savjetovanja o kliničkim, ispitivajima humanog leukocitnog interferona, 16 listopada 1974, JAZU; Zagreb, pp 105–108

  • Krušić J, Ikić D, Knežević M, Šooš E, Rode B, Jušić D Maricić Ž (1977) Clinical and histological finding after local application of human leukocyte interferon in patients with cervical cancer. Proc. Symp. on Preparation, Standardization, and Clinical Use of Interferon. 11th Internat. Immunobiol Symp Yug Acad Sci Arts, 8–9 June 1977, JAZU, Zagreb, pp 167–177

  • Koss LG (1978) Dryplasia — a real concept or a misnomer. J Obstet Gynecol [Reprints with modifications] 69–77

  • Naib ZM, Nahmias AJ (1978) Prospective study of herpesvirus infection and cervical anaplasia. Acta Cytol 22:606

    Google Scholar 

  • Patten SP (1976) Morphologic subclassification of preinvasive cervical neoplasia. In: Wied GL, Koss LG, Reagan JW (eds) Compendium on diagnostic cytology. Chicago, pp 112–124

  • Singer Z, Ikić D, Šooš E, Šips Dj, Jušić D, Smerdel S, Beck M (1979) Preventiva karcinoma ušća maternice humanim, leukocitnin interferonom. Zbornik radova Savjetovanja o kliničkim ispitivanjima interferona “Interferon, i tumori”, 21 ožujka 1979, JAZU, Zagreb, pp 70–80

  • Walton RJ et al. (1976) Cervical cancer screening programms. Can Med Assoc J 114:2–32

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ikić, D., Singer, Z., Beck, M. et al. Interferon treatment of uterine cervical precancerosis. J Cancer Res Clin Oncol 101, 303–308 (1981). https://doi.org/10.1007/BF00410115

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00410115

Key words

Navigation